Preliminary findings from the prospective multicenter surveillance, epidemiology and risk factors for thrombotic thrombocytopenic purpura (SERF-TTP) study.

被引：0

作者：

Zakarija, A

Bandarenko, N

Pandey, DK

Kwaan, H

McCaffrey, K

Finley, D

Carson, K

Yarnold, P

Bennett, CL

机构：

[1] Northwestern Univ, VA Midwest Ctr Hlth Serv & Policy Res, Div Hematol Oncol, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

[2] Univ N Carolina, Chapel Hill, NC USA

[3] Univ Illinois, Dept Neurol & Rehabil, Chicago, IL USA

来源：

BLOOD | 2004年 / 104卷 / 11期

关键词：

D O I：

10.1182/blood.V104.11.855.855

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

855

引用

页码：244A / 244A

页数：1

共 50 条

[21] Factors Influencing Time from Initial Presentation to Start of Plasma Exchange (PEX) in Patients with Acute Thrombotic Thrombocytopenic Purpura (TTP)
McCulloch, Rory
Bull, Tom
Nicolson, Phillip L. R.
Shaw, Rebecca J.
Sayar, Zara
Langridge, Alexander
Pettitt, Michala
Perry, Rita
Tucker, David
Scully, Marie
BLOOD, 2020, 136
[22] Risk factors for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following bone marrow transplantation (BMT).
Rizvi, MA
Vesely, SK
Roy, V
George, JN
BLOOD, 1999, 94 (10) : 16A - 17A
[23] Factors influencing time from initial presentation to start of plasma exchange (PEX) in patients with acute thrombotic thrombocytopenic purpura (TTP)
Bull, Tom
McCulloch, Rory
Nicolson, Phillip
Shaw, Rebecca J.
Sayar, Zara
Langridge, Alex
Pettit, Michala
Perry, Rita
Tucker, David
Scully, Marie
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 27 - 28
[24] Circulating endothelial cells and progenitors as prognosis factors during auto-immune thrombotic thrombocytopenic purpura: results of a prospective multicenter french study
Widemann, A.
Pasero, C.
Arnaud, L.
Poullin, P.
Loundou, A.
Choukroun, G.
Sanderson, F.
Lacroix, R.
Sabatier, F.
Coppo, P.
Dignat-George, F.
Kaplanski, G.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 87 - 87
[25] ELECTRON-MICROSCOPIC STUDY OF PLATELET-AGGREGATION INDUCED BY PLASMA FROM A PATIENT WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
LI, JZ
LIU, JW
BENITO, G
SIDDIQUI, FA
LIAN, ECY
EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 514 - 514
[26] Rituximab is an alternative to splenectomy in adults with chronic immune thrombocytopenic purpura: Results of a multicenter prospective phase 2 study.
Godeau, Bertrand
Fain, Olivier
Porcher, Raphael
Lefrere, Francois
Fenaux, Pierre
Cheze, Stephane
Vekhoff, Anne
Chauveheid, Marie-Paule
Stirnemann, Jerome
Galicier, Lionel
Bourgeois, Emmanuelle
Haiat, Stephanie
Varet, Bruno
Leporrier, Michel
Papo, Thomas
Michel, Marc
Bierling, Philippe
BLOOD, 2006, 108 (11) : 145A - 145A
[27] Prognostic, factors predicting survival and risk for relapse among patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS).
Vesely, SK
George, JN
Raife, TJ
Atkinson, BS
BLOOD, 2001, 98 (11) : 65B - 65B
[28] Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study
Kwok, S. K.
Ju, J. H.
Cho, C. S.
Kim, H. Y.
Park, S. H.
LUPUS, 2009, 18 (01) : 16 - 21
[29] Risk factors for post-ERCP pancreatitis: A prospective multicenter study.
Sherman, S
Lehman, G
Freeman, M
Watkins, J
Barnett, J
Fogel, E
Johanson, J
Geenen, J
Ryan, M
Parker, H
Lazaridis, E
Flueckiger, J
Silverman, W
Dua, K
Aliperti, G
Yakshe, P
Uzer, M
Jones, W
Goff, J
GASTROENTEROLOGY, 1998, 114 (04) : A497 - A497
[30] Risk factors for post-ERCP pancreatitis: A prospective multicenter study.
Sherman, S
Lehman, G
Earle, D
Watkins, J
Barnett, J
Johanson, J
Freeman, M
Geenen, J
Ryan, M
Parker, H
Lazaridis, E
Flueckiger, J
Silverman, W
Dua, K
Aliperti, G
Yakshe, P
Uzer, M
Jones, W
Goff, J
GASTROINTESTINAL ENDOSCOPY, 1997, 45 (04) : 562 - 562

← 1 2 3 4 5 →